Activation of the glucocorticoid receptor (GR) triggers apoptosis in T cells. However, activation of the T cell antigen receptor (TCR) blocks glucocorticoid-induced apoptosis, implying functional crosstalk between these two distinct signaling systems. By reconstructing or selectively blocking TCR-stimulated signaling pathways, we show here that TCR activation of the mitogen-activated protein kinase kinase͞extracellular signal regulated kinase (MEK͞ ERK) cascade via Ras is necessary and sufficient to inhibit GRmediated death in immortalized T and thymocyte cell lines and in primary T cells. Moreover, we found that activation of various pathway components (TCR, Ras, MEK1) altered the transcriptional regulatory activity of GR. In contrast, phosphatidylinositol 3-kinase and Akt, which down-regulate other lymphocyte apoptosis pathways, did not inhibit glucocorticoid-induced apoptosis. Our findings, which link signaling from the TCR cell surface receptor to that from the GR intracellular receptor, demonstrate the importance of the integration of signal transduction pathways in defining regulatory circuits. Because the TCR͞Ras͞MEK pathway has been shown previously to be essential for positive selection of thymocytes, the TCR͞Ras͞MEK signaling to GR crosstalk described herein may affect T cell development and homeostasis.
D
etermining how cellular signaling pathways influence each other is essential for understanding the complexities of physiology, pathology, and development. Integration of multiple signals is likely to be particularly important for signal transducers such as the glucocorticoid receptor (GR) that evoke different effects in different cells and physiologic settings (1) . GR, an essential and widely expressed transcriptional regulator, is triggered by hormone binding to translocate to the nucleus and associate with genomic glucocorticoid response elements (GREs), from which it activates or represses transcription depending on the cell and gene context (2, 3) . Thus, contextspecific factors, including signaling crosstalk, play essential roles in GR function.
In the immune system, GR represses cytokine and interleukin gene transcription and triggers programmed cell death (apoptosis) in T cells (4) . Glucocorticoid-induced apoptosis may help to eliminate developing T cells or thymocytes that are differentiating improperly (4) . Paradoxically, GR also promotes thymocyte survival. Mice with a thymus-specific reduction in GR produce only 10% of the normal numbers of thymocytes (5) . This dual effect of GR on thymocyte survival and apoptosis is reminiscent of the actions of the T cell antigen receptor (TCR), which is essential for thymocyte survival (positive selection) but can also cause apoptosis (negative selection; ref. 6 ). In the periphery, TCR signaling initiates the cellular immune response leading to T cell proliferation, differentiation into effector T cells, and generation of memory T cells (7) . Conversely, TCR stimulation of already activated mature T cells can induce apoptosis in a process known as activation-induced cell death (7) . Activation-induced cell death can be inhibited by glucocorticoids, indicating that GR can also mediate survival or apoptosis in mature T cells (8) .
TCR activation occurs in conjunction with the TCRassociated signaling complex CD3 (9) . Stimulation of the TCR͞ CD3 complex leads to recruitment and activation of Ras and Rac, small GTPases at the nexus of multiple signaling pathways (10) . Studies in transgenic mice reveal that dominant-negative mutants of Ras, Raf, and mitogen-activated protein kinase kinase 1 (MEK1) block positive selection but not negative selection, indicating that the two responses to TCR͞CD3 signaling must be governed by different pathways (11) .
TCR and GR trigger apoptosis via distinct pathways (12) . TCR-induced FasL interacts with its receptor, Fas, which activates caspase-8 (13, 14) . In contrast, GR-dependent transcription of unknown genes leads to activation of caspase-9 and subsequent apoptosis (15) (16) (17) (18) , which can be blocked by increased expression of Bcl-2 (19) .
Remarkably, simultaneous stimulation of GR and TCR results in T cell survival (4, 8) . Notch and CD28, two other T cell surface receptors that affect T cell development and function, also inhibit glucocorticoid-induced apoptosis (20, 21) . Calcineurin seems to be involved in inhibiting glucocorticoid-induced apoptosis by signals that mimic TCR͞CD3 (22) . Because TCR͞CD3 signals are essential for the proliferation and function of T cells in the periphery and are pivotal to the critical process of positive selection in the thymus, we were interested in the integration of GR and TCR signaling pathways that confers T cell survival. Others have shown that GR inhibits TCR-induced apoptosis by repressing FasL transcription (13) . We investigated the reciprocal pathway, in which TCR inhibits glucocorticoid-induced apoptosis, and its role in T cell survival.
Cell Stimulation and 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium Bromide (MTT) Assay. Cell stimulations were performed as described (26) with modifications as follows. Microtiter plates were coated with 10 g͞ml rabbit anti-hamster͞PBS (4°C, overnight). Cells (10 5 per ml) were incubated for 10 min with 0.5 g͞ml anti-CD3 (2C11 or 500-A2) and plated at 2 ϫ 10 4 cells per well, and dexamethasone (dex) was added. Kinase inhibitors were added 1 h before anti-CD3 stimulation. Viability was measured by MTT assay (27) . Absorbance was measured with a Molecular Devices Microplate reader (OD at 550 nm) with SOFTMAX 2.35 software.
Transient Transfections. Cells were electroporated as described (28) with 15 g of total DNA including 5 g of vector or kinase activator expression plasmid, 5 g of cytomegalovirus (CMV) long terminal repeat-␤-galactosidase (␤-gal), and 5 g of luciferase reporter construct or vector. At 12 h after transfection, cells were treated with 0.1 M dex with or without 0.5 g͞ml anti-CD3 and then harvested at 8 h for luciferase assay or at 24-30 h for ␤-gal viability assay (see below). Luciferase activity was measured in extracts with a luciferase assay kit from PharMingen, and ␤-gal activity was assayed as described (24) . Luciferase activity was normalized to ␤-gal activity.
␤-Gal Viability Assays. Treatments were performed at 12-14 h after transfection, and cells were harvested 30 h later or as indicated. ␤-gal activity was measured in cell extracts or in viable cells. ␤-gal assays were performed on cell extracts by using a chemiluminescent kit from Tropix (Bedford, MA). In viable cells, ␤-gal activity was determined by flow cytometry with fluorescein di-␤-D-galactopyranoside (FDG, Molecular Probes) and propidium iodide (PI; 30,000 events per sample). Percentage of FDG-positive (transfected)͞PI-negative (live) cells was determined by using a FACScalibur (Becton Dickinson) and CELLQUEST software. total PI-negative CD4
Immunoblotting. Whole-cell extracts from 10 7 cells per treatment were prepared as described (23) with some modifications. Cells were harvested and washed in PBS, and cell pellets were frozen in liquid nitrogen, resuspended in 50 l of lysis buffer [5% (vol/vol) glycerol͞400 mM NaCl͞10 mM Hepes, pH 7.9͞0.1 mM EGTA͞1 mM DTT͞1 mM PMSF͞1 g/ml each of leupeptin, pepstatin A, antipain, chymostatin, and aprotinin͞25 mM NaF͞2 mM ␤-glycerophosphate͞5 mM pyrophosphate] and then incubated for 30 min on ice. After centrifugation (10,000 ϫ g for 5 min at 4°C), supernatant was mixed with 2ϫ SDS-sample buffer and boiled for 3 min. Extracts for Bcl-2, Bcl-X L , and Bad were prepared as described (31) . Immunoblots were performed as recommended by the antibody manufacturer. GR immunoblots were performed with BUGR-2 as described (23) .
Results
Ras Inhibits GR-Mediated Apoptosis. To focus on TCR antagonism of glucocorticoid-induced apoptosis, we used a mutant of the murine T cell hybridoma, 2B4.11, that lacks Fas (13) . In contrast to the parental 2B4.11 cells, TCR͞CD3 stimulation of 2B4.11 (Fas-negative) cells with anti-CD3 antibody failed to induce apoptosis (Fig. 1A) . Nonetheless, TCR stimulation by anti-CD3 rescued these cells from GR-mediated apoptosis (Fig. 1 A) .
Stimulation of TCR͞CD3 results in the activation of a network of signaling pathways, some of which are diagrammed in Fig. 1B . We found that an activated mutant of Ras, RasV12 (32), completely abrogated glucocorticoid-induced apoptosis (Fig.  1 A) . RasV12 also protected S49 cells, a murine thymoma cell line (17, 33) from glucocorticoid-induced apoptosis (Fig. 1C) . In contrast, the inactive point mutant RasV12 S186 (34) gave no protection in 2B4.11 (Fas-negative) cells (Fig. 1D) . Thus, activated Ras could mimic the TCR͞CD3 signal that inhibits glucocorticoid-induced apoptosis.
Ras activates several downstream effector pathways (Fig. 1B) . To define the specific Ras-activated pathways that block glucocorticoid-induced apoptosis, we used RasV12 partial loss-offunction mutants that are pathway-selective (35) . We found that RasV12 S35, which activates Raf, partially rescued 2B4.11 (Fas-negative) cells from glucocorticoid-induced apoptosis (Fig.  1D) . RasV12 G37, which selectively activates Ral.GDS, a GTP exchange factor, also partially rescued 2B4.11 (Fas-negative) cells from glucocorticoid-induced apoptosis (Fig. 1D) Fig. 2A) .
Complementary with this finding, overexpression of a dominant-negative MEK mutant, MEK221A (38) , blocked TCR͞ CD3-mediated protection against glucocorticoid-induced apoptosis (Fig. 2 A) . Protection by activated RasV12 was also blocked by the MEK inhibitor PD98059 (ref. 39 ; Fig. 2 A) . We analyzed apoptosis with a TUNEL assay and found that TCR͞ CD3 inhibition of glucocorticoid-induced apoptosis was blocked completely by PD98059 (Fig. 2B) . The modest stimulation of apoptosis by PD98059 alone could not account for its effects in blocking TCR͞CD3 inhibition of glucocorticoid-induced apoptosis (Fig. 2B) . Another MEK1 inhibitor, U0126 (40), also blocked the TCR͞CD3 survival signal (data not shown). We conclude from these results that MEK1 activation by TCR͞CD3 stimulation and by Ras is necessary and sufficient to prevent glucocorticoid-induced apoptosis.
MEK1 Inhibits GR-Mediated Apoptosis in Primary T Cells.
Primary, unstimulated naïve mouse T cells are sensitive to glucocorticoidinduced apoptosis (41) . We tested whether the same TCR-GR crosstalk pathways that operate in immortalized T cells might also rescue primary T cells from glucocorticoid-induced apoptosis. Anti-CD3 stimulation of primary splenic T cells in culture strongly inhibited glucocorticoid-induced apoptosis (Fig. 2C) . This result suggested that the same crosstalk pathways may operate in primary T cells and established T cell lines. We investigated the role of the Ras͞MEK pathway with the MEK inhibitor PD98059 and found that it abrogated anti-CD3-induced resistance to dex killing in both CD4 ϩ and CD8 ϩ primary T cells (Fig. 2C) . We conclude that MEK activation is required for TCR͞CD3-mediated inhibition of glucocorticoidinduced apoptosis in naïve, primary T cells.
Phosphatidylinositol 3-Kinase (PI3-Kinase) and Akt Fail to Inhibit
GR-Mediated Apoptosis. Another signaling cascade activated by TCR͞CD3 and Ras is the PI3-kinase pathway. PI3-kinase has been shown to protect fibroblasts and neurons from apoptosis, triggered by withdrawal of serum or growth factors, through activation of Akt, a serine͞threonine kinase (34, 42, 43) . The Ras mutant RasV12 C40, which selectively activates PI3-kinase, protects fibroblasts from apoptosis (34) . RasV12C40, however, did not protect 2B4.11 (Fas-negative) cells from glucocorticoidinduced apoptosis (Fig. 3A) .
We found that activated mutants of the PI3-kinase catalytic subunit, p110, p110K227E, and p110CAAX, failed to inhibit glucocorticoid-induced apoptosis even though they activated Akt (Fig. 3 A and B; refs. 34 and 43). Inhibitors of PI3-kinase, LY294002 and wortmannin, markedly accelerated glucocorticoid-induced apoptosis in the absence of TCR͞CD3 stimulation (not shown) and therefore were uninformative. As expected, however, an activated mutant of Akt, v-Akt (34), failed to protect cells from glucocorticoid-induced apoptosis (Fig. 3A) . Similarly, expression of c-Akt or activated myristoylated-Akt (43) gave no protection (data not shown). These results indicate that TCR͞ CD3 inhibition of glucocorticoid-induced apoptosis does not involve PI3-kinase or Akt and is, therefore, distinct from previously identified cellular survival pathways (34, 43) .
Endogenous ERK Activity but Not Akt or Bad Correlates with TCR͞CD3
Survival Signal. Using phosphoisoform-specific antibodies in immunoblot analyses, we found that anti-CD3 stimulation of 2B4.11 (Fas-negative) cells activated the mitogen-activated protein kinases ERK1 and ERK2 (Fig. 4) , which are substrates of MEK (37) . Dex alone did not induce these kinases and did not affect their activation by anti-CD3 (Fig. 4) . As expected, PD98059 inhibited anti-CD3 activation of ERK1 and ERK2 (Fig.  4) . These results indicate that TCR͞CD3-mediated rescue from glucocorticoid-induced apoptosis correlated with activation of ERK1 and ERK2 by endogenous MEK.
GR-mediated apoptosis is blocked by increased expression of Bcl-2 and Bcl-X L (19, 41) . Conceivably, TCR͞CD3 stimulation might affect the expression of these antiapoptotic proteins. However, we found that Bcl-2 and Bcl-X L levels were unaffected by anti-CD3 or dex (Fig. 4 and data not shown) .
Finally, we examined the possibility that Akt phosphorylation (and thus inhibition) of the proapoptotic Bcl-2 family member Bad might be involved in the TCR-GR crosstalk pathway (44) . We found that steady-state accumulation of Akt and Bad proteins were largely unaffected by any of the treatments (Fig.  4) . Interestingly, anti-CD3 treatment induced phosphorylation of Akt and Bad. However, PD98059 inhibition of MEK activation had little or no effect on these modifications. Therefore, phosphorylation of Akt and Bad behaved independently of the CD3-activated antagonism of glucocorticoid-induced apoptosis, which is blocked by PD98059. This result is consistent with the failure of activated PI3-kinase and Akt to prevent GR-mediated apoptosis (see Fig. 3 ). We conclude that Bad inactivation by Akt does not reside in the TCR͞CD3 crosstalk pathway that confers protection from glucocorticoid-induced cell death.
GR Transcription Regulatory Activity Is Altered by TCR͞CD3, Ras, and
MEK. Glucocorticoid-induced apoptosis requires GR-mediated changes in gene transcription (18) . Hence, TCR͞CD3 crosstalk might affect GR directly, altering either its accumulation or its activity. As shown in Fig. 4 , TCR͞CD3 stimulation did not change GR protein levels, suggesting that TCR͞CD3 signaling was not operating on GR expression or turnover.
In T cells, glucocorticoids repress the transcription of many genes such as TCR-induced FasL, but the regulation of GRactivated genes in these cells is not well defined. GR-mediated activation of genes is thought to be important for glucocorticoidinduced apoptosis in mice (18, 45) , but the GR-regulated genes that confer apoptosis are unknown (17) . Therefore, to focus on how TCR͞CD3 and its downstream signaling cascades might affect GR transcriptional regulatory activity, we monitored expression of well characterized, ''surrogate'' reporter constructs. We used reporters associated with two distinct classes of GREs (2) . TAT 3 is a ''simple GRE'' (i.e., GR is the sole DNA-bound regulator), whereas the MMTV long terminal repeat contains a ''composite GRE'' (i.e., GR is one of several regulators that bind and interact; refs. 23 and 24). We transfected reporter plasmids bearing each class of GRE into 2B4.11 (Fas-negative) cells and assessed the effects of TCR͞CD3 signaling or cotransfected kinase activators on GR transcriptional activity.
We found that the signaling pathways that inhibit glucocorticoid-induced apoptosis significantly increased the transcriptional activity of GR at the simple GRE, TAT 3 (Fig. 5) . Anti-CD3, RasV12, and activated MEKR4F all enhanced transcriptional activation of TAT 3 by GR compared with treatment with dex alone. In contrast, these same crosstalk pathways had distinct effects at the MMTV composite GRE. RasV12 and MEKR4F suppressed GR activity (Fig. 5) . Together, these results demonstrate that crosstalk signaling from TCR͞CD3 clearly modulates the endpoint of GR signaling, its transcriptional regulatory activity. Strikingly, the consequence of TCR͞ CD3 crosstalk signaling is not hard wired but rather depends on the GRE at which the GR is acting.
Discussion
Signaling proteins such as GR and Ras can display either proapoptotic or antiapoptotic activity depending on cell context (4, 34) . We show herein that crosstalk between ubiquitous signaling proteins can produce context-specific effects on survival. Thus, a Ras effector pathway could inhibit GR-mediated apoptosis.
More specifically, gain-of-function, loss-of-function, and biochemical approaches were used to establish that TCR activation of the MEK͞ERK cascade via Ras was necessary and sufficient to inhibit GR-mediated death in primary and immortalized T cells. In turn, these pathways significantly altered GR transcriptional regulatory activity. Hence, the simplest interpretation of our results is that GR itself is the target of this crosstalk pathway.
Kinase Pathway Modulation of GR Activity. Consistent with our model, GR (46, 47) and other intracellular receptors (48) (49) (50) (51) can be phosphorylated by mitogen-activated protein kinases, and this modification seems to affect receptor transcriptional regulatory activity. As the GR target genes that induce apoptosis have not been identified, we monitored well defined ''surrogate'' GRE activities to assess the effects of the TCR͞CD3 crosstalk pathway on GR activity. It was important to test different classes of response elements, because regulatory effects are strongly context-dependent (2, 45) . Indeed, the signaling pathways that inhibit GR-mediated apoptosis significantly and differentially altered GR transcriptional regulatory activity at two distinct classes of GREs. Thus, our study adds a new layer to the multiple determinants of combinatorial control that together impart flexibility and specificity on the actions of GR and other transcriptional regulators. We suggest that the TCR͞CD3 crosstalk pathway likely has broad target-selective effects on GR transcriptional regulation.
GR in T Cell Development and Function.
Our results demonstrate that GR can inhibit TCR͞CD3 activation-induced death via MEK in primary splenic T cells. Thus, the same crosstalk pathway that we characterized in immortalized cells is also operative in mature, primary cells. In vivo glucocorticoid levels are governed by diurnal cycling and respond strongly to stress. Conceivably, the TCR-GR crosstalk pathway serves to inhibit the glucocorticoid-induced apoptosis of T cells that are combating stresses such as infection or inflammation.
We also found that Ras signaling in a thymoma cell line, S49, prevented glucocorticoid-induced apoptosis, perhaps implying that the same crosstalk pathways operate in thymocytes. Thymocytes undergo selection processes to ensure TCR and coreceptor combinations that are functional but nonresponsive to self-antigens (6). Ashwell and coworkers (4, 52, 53) showed that reduced GR protein in thymocytes can alter the T cell repertoire. Notably, the TCR͞Ras͞MEK͞ERK pathway implicated in positive selection (11) is the same pathway that we have shown to inhibit glucocorticoid-induced apoptosis. It is possible that during T cell development, the TCR͞CD3-activated Ras͞MEK͞ ERK pathway confers positive selection at least in part by rescuing cells from glucocorticoid-induced apoptosis. That is, glucocorticoid-induced apoptosis may impose a key restriction that makes TCR signaling via Ras activation of MEK compulsory for thymocyte survival. Confirmation of this hypothesis requires further experimentation.
Glucocorticoids, Homeostasis, and the Immune Repertoire. The specificity of responses to steroid hormones is likely to be determined by a combination of physiological, cellular, and gene contexts (2, 54) . More generally, however, steroids maintain differentiation and homeostasis in many tissues such prostate (testosterone), mammary (estrogens), and endometrial (progesterone) epithelia (55) . We suggest that glucocorticoids play a homeostatic role in T cell development and function, balancing the signaling strength of TCR and GR to promote selective cell survival. Thus, fluctuations in glucocorticoid levels that occur in response to diurnal cycling or stress would shift the spectrum of surviving T cells at different times, thereby producing a net expansion in the T cell repertoire.
Our identification of the components of this crosstalk pathway is also of potential clinical value, because it suggests a new layer of regulators that influence hormonal efficacy. For example, dex is initially efficacious for treatment of lymphoma and acute lymphocytic leukemia but progression to dex resistance is commonly encountered (56) . Activating N-Ras point mutations have been described in some dex-resistant cases of acute lymphocytic leukemia (57) , perhaps implicating the crosstalk pathway that we have characterized. Inhibition of Ras in tumor cells may resensitize them to hormone therapy.
The GR and the TCR are essential and highly sensitive detectors and transducers of extracellular stimuli. Defining the interactions of their pathways will advance our understanding of the signaling crosspoints that determine cell life or death.
